Test Price
2,800 AED✅ Home Collection Available
MCEE Gene Methylmalonyl‑CoA Epimerase Deficiency Genetic Test in UAE | 2 800 AED | 2026 DHA Guidelines
تحليل جين MCEE لنقص إبيميراز ميثيل مالونيل-كو أ في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection with ISO‑certified cold‑chain transport (8 AM – 11 PM).
- Clinical Guidance: Complimentary telephonic post‑test interpretation by a DHA‑licensed genetic counsellor.
- Insurance: Instant direct billing verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي
- الدقة: حساسية تشخيصية بنسبة 99.9% عبر مختبر معتمد ISO 9001:2015.
- الخدمة اللوجستية: سحب منزلي عالي الجودة بسلسلة تبريد معتمدة (8 صباحاً – 11 مساءً).
- التوجيه السريري: استشارة هاتفية بعد النتيجة من مستشار جيني مرخص.
- التأمين: التحقق الفوري من التغطية عبر واتساب +971 54 548 8731.
Clinical Overview & Test Comparison
This next‑generation sequencing (NGS) test analyses the entire coding region of the MCEE gene to detect pathogenic variants causing Methylmalonyl‑CoA Epimerase Deficiency, a rare autosomal recessive organic aciduria. يكتشف هذا الفحص الطفرات الوراثية المسؤولة عن نقص الإبيميراز بدقة عالية.
| Feature | Our Test (MCEE NGS) | Standard Biochemical Screen |
|---|---|---|
| Technology | Full‑gene Next‑Generation Sequencing (Illumina® platform) | Urine organic acid analysis (GC‑MS) |
| Diagnostic Specificity | >99.9% – identifies variants of uncertain significance with expert curation | Moderate – may miss mild or intermittent cases |
| Turnaround Time | 3–4 weeks | 5–10 business days |
| Clinical Utility | Definitive molecular confirmation, carrier testing, prenatal/preimplantation genetic diagnosis | Initial screening; requires genetic follow‑up for confirmation |
Physician Insight & Safety Protocol
“As a clinical geneticist, I understand the deep anxiety surrounding metabolic diagnoses. This MCEE gene test provides the definitive molecular answer that families need for informed decision‑making. However, it must always be interpreted in conjunction with biochemical and clinical findings – never in isolation.”
– Dr. PRABHAKAR REDDY, DHA License: 61713011, Consultant Clinical Genetics
🚨 Medication Warning
Do not discontinue prescribed medication (e.g., carnitine, vitamin B12, or metabolic formulas) without consulting your doctor. Abrupt changes can trigger a metabolic crisis.
Exclusion Criteria & Emergency Red Flags
- Exclusion for home collection: Patients currently in acute metabolic decompensation (hyperammonaemia, severe acidosis, altered consciousness) or with active infection/fever >38.5 °C – sample collection must be deferred.
- Emergency Red Flags: If the patient develops vomiting, lethargy, rapid breathing, or seizures after the test but before results, proceed immediately to the nearest Emergency Department. This is a possible metabolic crisis and is unrelated to the blood draw.
UAE Regulatory & Clinical Coding
- ICD‑10‑CM (2026): E71.128 (Other methylmalonic acidemias), Z13.79 (Screening for genetic anomalies), Z14.8 (Genetic susceptibility to disease)
- LOINC: 101334‑8 – MCEE gene full mutation analysis
- Lab Facility License (DHA): 9834453
- ISO 9001:2015 Certificate: INT/EGQ/2509DA/3139
- Legal Framework: Fully compliant with Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 (mandatory parental consent for minors), and UAE PDPL (genomic data encryption).
- Specialist Referrals: Medical Geneticist (hereditary workup), Metabolic Medicine Consultant (long‑term management), Paediatrician (neonatal/paediatric screening).
Patient FAQ & Clinical Guidance
1. What is the MCEE Gene Methylmalonyl‑CoA Epimerase Deficiency Genetic Test?
The MCEE genetic test identifies pathogenic variants in the methylmalonyl‑CoA epimerase gene, enabling precise diagnosis of this organic aciduria. This non‑invasive molecular assay screens the entire coding sequence, providing clarity for affected individuals and at‑risk family members.
يكتشف اختبار MCEE الجيني الطفرات المسببة لنقص إبيميراز ميثيل مالونيل-كو أ، مما يتيح تشخيصاً دقيقاً لهذا الاضطراب الأيضي.
2. How long does it take to receive the results?
Results are typically available within 3 to 4 weeks, allowing timely clinical decision‑making for affected families. This interval includes DNA extraction, library preparation, sequencing, bioinformatics analysis, and clinical interpretation. An expedited report is available upon medical request.
تتوفر النتائج عادةً خلال 3 إلى 4 أسابيع، مما يتيح اتخاذ القرارات السريرية في الوقت المناسب للعائلات المصابة.
3. Is the test covered by health insurance in the UAE?
Many UAE insurers reimburse this diagnostic genetic when pre‑authorized; our team handles direct billing verification. Please send your insurance card photo via WhatsApp to +971 54 548 8731 for instant eligibility confirmation before sample collection.
تُغطي العديد من شركات التأمين في الإمارات هذا الاختبار التشخيصي الجيني بعد الموافقة المسبقة؛ ويتولى فريقنا التحقق المباشر من التغطية.
Tests are performed in a DHA‑licensed facility (license 9834453). All genetic data is processed in compliance with UAE PDPL and ISO 9001:2015 standards. © 2026 – Trusted by UAE clinicians.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians